Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population

被引:61
作者
Vuilleumier, P [1 ]
Decosterd, D [1 ]
Maillard, M [1 ]
Burnier, M [1 ]
Hayoz, D [1 ]
机构
[1] CHUV, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland
关键词
cardiovascular risk; cutaneous; hyperemia; laser Doppler; women;
D O I
10.1097/00004872-200209000-00018
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To examine whether forearm postischemic skin reactive hyperemia (SRH) measured by laser Doppler flowmetry (LDF) can be used to explore microvascular function and whether LDF response is related to cardiovascular (CV) risk in a population study. Methods SRH of the forearm defined as the percentage increase in cutaneous blood flow from resting conditions to peak dilation following a 2 min upper arm occlusion and CV risk factors were measured prospectively in 862 healthy females screened for cardiovascular risk factors in the context of a campaign designed to promote the control of CV risk factors in women. Results The Framingham risk score was constructed from age, sex, systolic and diastolic blood pressure, diabetes, total and high-density lipoprotein-cholesterol and left ventricular hypertrophy (Cornell product. The Cornell product for women was calculated as the QRS duration (ms) x (R aVL + S V3 + 6 mV)). Although the score was low in this female population (CV event risk at 10 years 7.89) (95% confidence interval, 7.49-8.30) aged 40 to 75 years, we observed an inverse correlation between SRH of the forearm and the CV risk score (P < 0.001). Hormonal replacement therapy (39.4% of the study population was on hormone replacement therapy) had no significant influence on forearm postischemic SRH in this particular population. Conclusions This study shows that in a very low CV risk female population, a significant correlation can be observed between the weight of CV risks and the impairment of postischemic forearm SRH. Thus, skin laser Doppler flowmetry may represent a valuable, simple and non-invasive tool to assess and monitor microvascular function in future prospective observational and interventional studies. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1753 / 1757
页数:5
相关论文
共 22 条
[1]  
AALKJAER C, 1989, J HYPERTENS, V7, P305
[2]   Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes [J].
Caballero, AE ;
Arora, S ;
Saouaf, R ;
Lim, SC ;
Smakowski, P ;
Park, JY ;
King, GL ;
LoGerfo, FW ;
Horton, ES ;
Veves, A .
DIABETES, 1999, 48 (09) :1856-1862
[3]   RESTING AND MAXIMAL FOREARM SKIN BLOOD FLOWS ARE REDUCED IN HYPERTENSION [J].
CARBERRY, PA ;
SHEPHERD, AMM ;
JOHNSON, JM .
HYPERTENSION, 1992, 20 (03) :349-355
[4]   Calf and forearm blood flow in hypercholesterolemic patients [J].
Cortella, A ;
Zambon, S ;
Sartore, G ;
Piarulli, F ;
Calabrò, A ;
Manzato, E ;
Crepaldi, G .
ANGIOLOGY, 2000, 51 (04) :309-318
[5]   ENDOTHELIAL FUNCTION IN CHRONIC CONGESTIVE-HEART-FAILURE [J].
DREXLER, H ;
HAYOZ, D ;
MUNZEL, T ;
HORNIG, B ;
JUST, H ;
BRUNNER, HR ;
ZELIS, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (19) :1596-1601
[6]   Contribution of nitric oxide and prostaglandins to reactive hyperemia in the human forearm [J].
Engelke, KA ;
Halliwill, JR ;
Proctor, DN ;
Dietz, NM ;
Joyner, MJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (04) :1807-1814
[7]   Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].
Fichtlscherer, S ;
Rosenberger, G ;
Walter, DH ;
Breuer, S ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2000, 102 (09) :1000-1006
[8]   Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia [J].
Haak, E ;
Abletshauser, C ;
Weber, S ;
Goedicke, C ;
Martin, N ;
Hermanns, N ;
Lackner, K ;
Kusterer, K ;
Usadel, KH ;
Haak, T .
ATHEROSCLEROSIS, 2001, 155 (02) :395-401
[9]   POSTISCHEMIC BLOOD-FLOW RESPONSE IN HYPERCHOLESTEROLEMIC PATIENTS [J].
HAYOZ, D ;
WEBER, R ;
RUTSCHMANN, B ;
DARIOLI, R ;
BURNIER, M ;
WAEBER, B ;
BRUNNER, HR .
HYPERTENSION, 1995, 26 (03) :497-502
[10]  
Hayoz D, 1998, ADV EXP MED BIOL, V449, P447